Elevated Triglyceride Levels and Later Type 2 Diabetes

July 19, 2011 updated by: University of Tromso
Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

3509

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
      • Tromsø, Norway, 9037
        • Univesity of Tromsø

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels

Description

Inclusion Criteria:

  • participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

Exclusion Criteria:

  • type 2 diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
participants in the 4th Tromsø study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT)
Time Frame: At study enrollment in 2010
At study enrollment in 2010

Secondary Outcome Measures

Outcome Measure
Time Frame
The relation between serum 25(OH)D levels and blood glucose levels at OGTT
Time Frame: At study enrollment in 2010
At study enrollment in 2010

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Tromso

Investigators

  • Principal Investigator: rolf jorde, md, University of Tromso

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

November 1, 2010

Study Registration Dates

First Submitted

August 11, 2010

First Submitted That Met QC Criteria

August 16, 2010

First Posted (Estimate)

August 17, 2010

Study Record Updates

Last Update Posted (Estimate)

July 20, 2011

Last Update Submitted That Met QC Criteria

July 19, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UIT-ENDO-2010-3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe